NARATRIPTAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Naratriptan, and when can generic versions of Naratriptan launch?
Naratriptan is a drug marketed by Ani Pharms, Apotex Corp, Aurobindo Pharma Usa, Chartwell Rx, Heritage Pharms, Hikma, Orbion Pharms, Padagis Us, and Sun Pharm Inds Ltd. and is included in nine NDAs.
The generic ingredient in NARATRIPTAN is naratriptan hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the naratriptan hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NARATRIPTAN?
- What are the global sales for NARATRIPTAN?
- What is Average Wholesale Price for NARATRIPTAN?
Summary for NARATRIPTAN
US Patents: | 0 |
Applicants: | 9 |
NDAs: | 9 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Clinical Trials: | 10 |
Patent Applications: | 3,838 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for NARATRIPTAN |
DailyMed Link: | NARATRIPTAN at DailyMed |
![NARATRIPTAN drug patent expirations Drug patent expirations by year for NARATRIPTAN](/p/graph/s/t/NARATRIPTAN-patent-expirations.png)
![Drug Prices for NARATRIPTAN](/p/graph/drug-price/NARATRIPTAN.png)
Recent Clinical Trials for NARATRIPTAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
AgoneX Biopharmaceuticals, Inc. | Phase 2 |
BioHealthonomics Inc. | Phase 2 |
Ache Laboratorios Farmaceuticos S.A. | Phase 3 |
Pharmacology for NARATRIPTAN
Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
US Patents and Regulatory Information for NARATRIPTAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ani Pharms | NARATRIPTAN | naratriptan hydrochloride | TABLET;ORAL | 078751-001 | Jul 7, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Rx | NARATRIPTAN | naratriptan hydrochloride | TABLET;ORAL | 090288-001 | Jul 7, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Apotex Corp | NARATRIPTAN | naratriptan hydrochloride | TABLET;ORAL | 091373-002 | Apr 22, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hikma | NARATRIPTAN | naratriptan hydrochloride | TABLET;ORAL | 090381-002 | Jul 7, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |